A simple, sensitive and reliable reversed phase Rapid Resolution Liquid Chromatography (RRLC) method was developed and validated for six biologically active compounds (salidroside, tyrosol, rosarin, rosavin, rosin and rosiridin) in Rhodiola rosea L. roots and powder extracts. The method uses a Phenomenex C18 (2)-HST column at 40 o C with a neutral gradient system mobile phase (H 2 O and acetonitrile), a flow rate of 1.0 mL/min, and UV detection wavelengths set at 205 and 254 nm, simultaneously. Baseline separation of the six active compounds was achieved within 8 minutes. The average percentages of rosavins (rosarin, rosavin, and rosin) in authentic R. rosea roots and root powder extracts were quantitatively determined and a characteristic R. rosea roots RRLC profile was established. The RRLC method is accurate and sensitive; in addition, it effectively increases the sample analysis throughput compared with conventional HPLC.
The Rhodiola genus consists of more than two hundred species, at least twenty of which have been used in traditional Chinese medicine [1] . Among them, R. rosea L. (also known as golden root and Arctic root) is the best known species. R. rosea is a perennial plant with a thick rhizome and a rose-like fragrance when cut [2] . The plant is distributed in Arctic regions of Europe, Asia and North America. For centuries it has been used in eastern European and Asian cultures as a tonic and adaptogen to aid physical endurance, extend longevity, protect against altitude sickness and help to treat fatigue, depression, anemia, impotence, gastrointestinal ailments, infections and nervous system disorders [3, 4] .
The traditional medicinal uses of R. rosea have been wellestablished, and numerous in vitro and in vivo studies have been conducted on animals. For example, the CNS stimulating, neuro-, cardio-and hepato-protective effects, life-span increasing, immunotropic, antiviral, antiinflammatory and antibacterial activities of R. rosea have been demonstrated [5] .
Phytochemical investigations showed the existence of three classes of important active constituents in R. rosea, namely, phenylethanoids (salidroside, tyrosol), phenylpropanoid glycosides (rosarin, rosavin, rosin), and a monoterpene (rosiridin) [6] . In the 1970s, salidroside was believed to be the compound responsible for the pharmacological properties in R. rosea roots; therefore, the first generation of R. rosea root tinctures and root powder extracts were standardized to a minimum of 0.8% salidroside content (w/w) [7] . Salidroside is present in many species including R. rosea, R. quadrifida, R. algila, R. sachalinensis, R. kirilowii, R. crenulata, R. heterodonta and R. semenovii [5] . Similarly, tyrosol has also been found in all studied species of Rhodiola [8, 9] . A characteristic feature of R. rosea is the presence of rosavins, which has not been detected in the other 21 Rhodiola species that are morphologically similar to R. rosea [5] . On the market, the term rosavins is used to identify the three phenylpropanoid glycosides: rosarin, rosavin and rosin [10, 11] . Recently, rosavins has attracted particular interest because of its antidepressant, anticancer, neurotropic, immune-stimulating and hepato-protective properties in some animal experiments [5] . Current market production of commercial R. rosea root powder extracts is standardized for the contents of both salidroside and rosavins. In addition, the rosiridin content of R. rosea is about 3% (w/w) and should also be used as a diagnostic marker compound [12] . Literature survey reveals that a variety of methods have been reported to analyze the active constituents of R. rosea using capillary zone electrophoresis [13] [14] [15] , liquid chromatography (LC) coupled with UV [4, [16] [17] , and MS [18] [19] [20] [21] . Unfortunately, all of these methods use acid in the mobile phase and suffer from both a long analysis time of more than 30 minutes and large quantities of solvent consumption. With the objective of reducing analysis time while maintaining efficiency, RRLC became one of the most frequently applied methods due to its high sensitivity and high-speed detection with reduced analysis cost. In this study, a RRLC method was established and validated for the quantitative and qualitative analysis of the six active compounds in R. rosea: (1) salidroside, (2) tyrosol, Figure 2 ). In addition, the absorption of salidroside at 254 nm was very weak, and tyrosol was under the limit of quantification (LOQ). Therefore, a detection wavelength was selected at 205 nm to analyze the six bioactive compounds in R. rosea products in a single run. Prior to sample analysis, the optimal extraction conditions of the biologically active compounds in R. rosea were compared. Previous work by Ma et al. [6] showed that refluxing and ultrasonication using MeOH produced comparable extraction yields of rosavins. In this study, ultrasonication was selected for its simplicity and shorter extraction time [22] . Variables in the extraction procedures, such as solvent strength and extraction time were optimized on an authentic R. rosea root sample (H3). As shown in Figure 3 , the extraction yield of rosavins increased as the concentration of MeOH in H 2 O (v/v) increased from 20% to 75%; further increases of MeOH concentration to 100% had a negative effect on rosavins extraction yield. Figure 3 shows that both 15 and 20 minutes of ultrasonication resulted in comparable results for rosavins content, indicating that 15 minutes of ultrasonication was sufficient for R. rosea root extraction. The highest extraction effectiveness was achieved with 75% MeOH aq. solution with 15 minutes of ultrasonication at 37 o C. Calibration curves were prepared by plotting the peak area against the corresponding concentrations of analytes. The regression lines are linear in the concentration range studied and the corresponding coefficients of correlation are shown in Table 1 . Rosiridin reference standard was used only for identification purposes in the analysis. Peaks were assigned by spiking the samples with standard compounds, and comparing the UV spectra and retention time. Good linear relationships (r=0.9997 for salidroside, 0.9999 for tyrosol, rosarin, rosavin and rosin) were demonstrated over a range of 50-800 μg/mL. Figure 4A shows the separation of the mixed marker compounds: (1) salidroside, (2) tyrosol, (3) rosarin, (4) rosavin, (5) rosin and (6) rosiridin.
The precision of the developed method was determined by analyzing the same mixed standard solution in triplicate. As shown in Table 1 , the relative standard deviation (RSD) of the relative retention time and relative peak area were less than 0.79%, indicating that this RRLC method was precise for the quantitative analysis of the major active compounds in R. rosea. The accuracy of this method was evaluated by using the recovery test, which was performed by spiking a known quantity of the five references to 0.1 g of authentic R. rosea root extract (P5-Lot3). The fortified samples were then extracted and analyzed in triplicate. The results of the recovery tests were obtained by comparing the results of the original samples with the fortified samples. The mean recoveries were from 98.9% to 100.9%, with RSD less than 1.42%. These results suggest that the RRLC method has good repeatability, precision, accuracy and recovery, making RRLC a reliable and useful method for the quality control of R. rosea roots.
Nine samples of Rhodiola roots have been analyzed by the described method. Figures 4B, 4C , and 4D show the characteristic RRLC chromatograms of authentic R. rosea dried roots (H3), fresh roots (H5), and commercial powder extract (P5-Lot3), respectively. The optimum extraction and RRLC analysis method were applied to 18 commercial samples of R. rosea root powder extracts collected from eight suppliers to calculate and compare the contents of the five marker compounds. As shown in Table 2 , the characteristic marker compounds rosarin, rosavin, and rosin were not detected in six out of eighteen (33.3%) commercial Rhodiola powder extracts (P1-Lot1, P3-Lot1, P6-Lot1, P6-Lot2, P8-Lot1, and P8-Lot2). In addition, five out of eighteen (27.8%) commercial R. rosea powder extracts (P3-Lot2, P4-Lot1, P5-Lot2, P7-Lot1, and P7-Lot2) did not meet the claimed contents standards for the marker compounds. Among these five samples, two contained less salidroside than the label claim; the other three had either lower rosavin or rosavins content. This allows us to conclude that the establishment of this RRLC analysis method is necessary to monitor and regulate the quality of products in the Natural Health Products industry.
The quantitative analytical results indicate that the variations in the content of the marker compounds of the commercial R. rosea powder extracts were high, even among the samples collected from the same supplier.
Analyses revealed that the characteristic rosavins peaks were not detected in about 33.3% of the commercial Rhodiola root powder extract samples. In addition, the quantification analyses revealed a large variation between the actual rosavins content and the amount claimed by suppliers. Health Canada, FDA and many other Natural Health Product Regulatory Affairs departments are becoming stricter with the identification of herbs and botanical products. In the Natural Health Product industry, it is crucial to establish an RRLC profile not only to differentiate R. rosea from other species, but also to evaluate and control the quality of commercial R. rosea related products.
It is well known that Chinese medicine preparations with different pretreatment processes, manufacturing procedures, and dosage forms will be of different quality. As well, the content of bioactive markers is also affected by plant origins, sources, cultivation year, harvest time, geographical climate and environment. All of these could result in significant differences in the quality of R. rosea roots. However, as shown in Figure 5 , the percentages of rosavins (rosarin, rosavin, and rosin) in twelve confirmed R. rosea root powder extract samples and five authentic R. rosea roots samples are relatively constant, except for sample P5-Lot5, which was claimed to have a 10% salidroside content. The average percentages of rosarin, rosavin and rosin are 24.3%, 59.3% and 16.4%, respectively. Furthermore, no significant difference was observed in the composition of rosavins between confirmed commercial R. rosea root powder extracts and authentic R. rosea roots, indicating that the chemical profile of R. rosea roots does not change during the extraction process. Our results also showed that the established RRLC method enjoyed the practical advantages of shorter analysis times and reduced quantity of solvent consumption. This makes the RRLC method an attractive alternative to the conventional HPLC technique for routine QC analysis, especially when high sample throughput and fast analytical speed is required.
Experimental

Chemicals and materials:
The reference standards of salidroside, tyrosol, rosarin, rosavin, and rosin were obtained from ChromaDex (Irvine, USA). The purities of these 5 standards were not less than 98%. The reference standard of rosiridin was obtained from Biopurify (Chengdu, China), which was used only for identification purpose. 
Standard solutions and sample preparation:
The stock reference standard solution of salidroside, tyrosol, rosarin, rosavin, and rosin was prepared at a concentration of 1.0 mg/mL in MeOH. Further calibration levels were prepared by diluting the above reference standard solution to 0.2, 0.4, 0.6, and 0.8 mg/mL. All solutions were stored in a refrigerator at 4 o C.
About 5 g of dried R. rosea roots was ground into fine powder and accurately weighed into a 10 mL volumetric flask, ultrasonic extracted at 37 o C with 75% MeOH aq. solution for 15 min, and then made up to volume. Prior to RRLC analysis, all samples were filtered through a 0.20 μm syringe filter purchased from VWR International (Mississauga, Canada). Every sample was injected in triplicate and the RSD was calculated for all the samples. For Rhodiola powder extracts, the same procedures were followed except using pure MeOH as extraction solvent.
Chromatography conditions: RRLC analysis was carried out using an Agilent series 1200 RRLC instrument (Agilent, CA, US) equipped with a binary pump, a micro vacuum degasser, a multi-wavelength (MW) detector, an autosampler, and a thermostated column. Optimum resolution and peak shape were obtained on a Luna C18-HST column (2.5 μm, 100 × 3.0 mm) from Phenomenex (Torrance, CA, USA). The mobile phase consisted of purified H 2 O (A) and CH 3 CN (B). The linear gradient was as follows: 0-6 min, 6-17% B; 6-7 min, 17-19.7% B; 7-9 min, 19.7-19.7% B, 9-10 min, 19.7-100% B at a flow rate of 1.0 mL/min. The column temperature was 40 o C, detection wavelength 205 and 254 nm, and injection volume 1 µL. Each run was followed by a 2 min post run and an equilibration period of 5 min.
